TLR4 and breast carcinoma: Results of the Western blot analysis showed that the CV extract decreased the LPS-induced activation of TLR4 both in HUVEC endothelial cells (Figure 6B; p < 0.05) and MCF-7 breast cancer cells (Figure 6D; p < 0.05).